Westlake Chemical shares experienced downward pressure in recent trading, declining by 1.16 percent to settle at $86.01. This movement extends a broader negative trend for the equity.
Earnings Report Falls Short of Expectations
The company’s August quarterly release significantly impacted investor sentiment with results that missed analyst projections across key metrics:
- Earnings Per Share: Reported a loss of $0.09, contrasting with the anticipated profit of $0.06
- Revenue: Totaled $2.95 billion, falling short of the $3 billion forecast
- Year-Over-Year Sales: Declined by 7.9 percent compared to the same period last year
These weaker-than-expected figures resulted in a net margin of negative 0.57 percent. Market attention is now turning to the upcoming Q3 results, anticipated for release in November.
Mixed Signals from Institutional Investors
Activity among major institutional holders has been varied. Millennium Management LLC aggressively increased its stake by 366.7 percent in the first quarter, building a position exceeding 900,000 shares. Similarly, Vident Advisory LLC grew its investment by a substantial 426.3 percent. Conversely, Jacobs Levy Equity Management Inc. reduced its holdings by 2.9 percent, indicating a more cautious outlook.
Should investors sell immediately? Or is it worth buying Westlake Chemical?
Analyst Sentiment Remains Cautiously Positive
Despite the stock’s recent weakness, the general analyst consensus maintains a guardedly optimistic stance. The average price target currently sits at $92.29, accompanied by a “Moderate Buy” recommendation. This outlook follows some notable adjustments: Truist Financial revised its target down from $117 to $92, though it reaffirmed its “Buy” rating. In a contrasting move, Tudor, Pickering, Holt & Co. upgraded its rating from “Hold” to “Buy” in August.
Dividend Stability and Strategic Growth Initiatives
Amid operational challenges, Westlake Chemical has reaffirmed its commitment to returning capital to shareholders. The company continues its dividend distribution of $0.53 per share, which provides a current yield of approximately 2.4 percent.
In a strategic push for growth, the firm announced the acquisition of the global compounding solutions division of the ACI/Perplastic Group in late August. This purchase is designed to bolster expansion within its Housing & Infrastructure Products segment. Alongside this growth strategy, Westlake is pursuing ambitious environmental targets, including a planned 20 percent reduction in CO2 emissions by 2030.
Ad
Westlake Chemical Stock: Buy or Sell?! New Westlake Chemical Analysis from September 10 delivers the answer:
The latest Westlake Chemical figures speak for themselves: Urgent action needed for Westlake Chemical investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 10.
Westlake Chemical: Buy or sell? Read more here...